BIRC5 stimulates cellular apoptosis, diminishes the growth capacity of tumours, and renders cancerous cells more susceptible to chemotherapeutic agents (e.g., etoposide, Taxol, cisplatin), immunotherapy, and gamma radiation [29]. The gene discussed is BIRC5; the disease is neoplasm.